Biome Australia (ASX:BIO) Capex-to-Revenue : 0.02 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biome Australia Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Biome Australia's Capital Expenditure for the six months ended in Dec. 2024 was A$-0.18 Mil. Its Revenue for the six months ended in Dec. 2024 was A$8.86 Mil.

Hence, Biome Australia's Capex-to-Revenue for the six months ended in Dec. 2024 was 0.02.

Biome Australia Capex-to-Revenue Historical Data

The historical data trend for Biome Australia's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biome Australia Capex-to-Revenue Chart

Biome Australia Annual Data

Trend

Jun22

Jun23

Jun24

Capex-to-Revenue

0.03

0.06

Biome Australia Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Capex-to-Revenue	Get a 7-Day Free Trial			0.08	0.04	-	-	0.02

Competitive Comparison of Biome Australia's Capex-to-Revenue

For the Packaged Foods subindustry, Biome Australia's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biome Australia's Capex-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biome Australia's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biome Australia's Capex-to-Revenue falls into.

Save Embed

;

Save Embed

;

Biome Australia Capex-to-Revenue Calculation

Biome Australia's Capex-to-Revenue for the fiscal year that ended in Jun. 2024 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.022)	/	13.009
	=	0.00

Biome Australia's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.181)	/	8.864
	=	0.02

Biome Australia (ASX:BIO) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Biome Australia Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biome Australia's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biome Australia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biome Australia Ltd (ASX:BIO) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

192-194 Johnston Street, Collingwood, VIC, AUS, 3066

Website

https://www.biomeaustralia.com

Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals food-based vitamins and weight management products and live biotherapeutics. The firm owns brands namely; Activated Nutrients: a range of completely organic, plant-based, all-in-one nutritional products; Activated Probiotics: a first-of-its-kind range of clinically-backed precision probiotics. The company has one operating segment: researching, developing, manufacturing and distributing innovative evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.